Literature DB >> 358815

Dose-independent pharmacokinetics of digoxin in humans.

H R Ochs, D J Greenblatt, G Bodem, J S Harmatz.   

Abstract

Nine healthy male volunteers received single 0.5, 1.0, and 1.5 mg. doses of intravenous digoxin in a randomized three-way crossover study. Multiple venous blood samples were drawn during 35 hours after each dose, and all urine was collected for 6 consecutive days. Concentrations of digoxin in serum and urine were determined by radioimmunoassay. Over-all mean values for kinetic variables were: distribution half-life, 0.35 hours; elimination half-life, 27.9 hours; volume of distribution, 5.46 liters/Kg; total clearance, 2.51 ml./min./Kg. The mean projected cumulative urinary excretion of digoxin was 70.1% of the dose; mean renal clearance of digoxin was 1.71 ml./min./Kg., not significantly different from creatinine clearance (1.50 ml./min./Kg.). None of the identifiable pharmacokinetic variables was significantly influenced by dose, suggesting that digoxin disposition is dose-independent in healthy individuals.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 358815     DOI: 10.1016/0002-8703(78)90162-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  15 in total

1.  Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose.

Authors:  B Oosterhuis; J H Jonkman; T Andersson; P B Zuiderwijk; J N Jedema
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

2.  Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens.

Authors:  Daniel Moj; Nina Hanke; Hannah Britz; Sebastian Frechen; Tobias Kanacher; Thomas Wendl; Walter Emil Haefeli; Thorsten Lehr
Journal:  AAPS J       Date:  2016-11-07       Impact factor: 4.009

3.  Effect of dose on bioavailability of oral digoxin.

Authors:  H R Ochs; G Bodem; D J Greenblatt
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

Review 4.  Disease-related alterations in cardiac glycoside disposition.

Authors:  H R Ochs; D J Greenblatt; G Bodem; H J Dengler
Journal:  Clin Pharmacokinet       Date:  1982 Sep-Oct       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of digoxin 1980.

Authors:  J K Aronson
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

6.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

7.  Pharmacokinetics and pharmacodynamics of intravenous digoxin and digitoxin.

Authors:  H R Ochs; E Grube; D J Greenblatt; R Arendt; G Bodem
Journal:  Klin Wochenschr       Date:  1981-08-17

8.  Skeletal muscle digoxin concentration during digitalization and during withdrawal of digoxin treatment.

Authors:  T Jogestrand; F Ericsson; K Sundqvist
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

9.  Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.

Authors:  Jens Rengelshausen; Christoph Göggelmann; Jürgen Burhenne; Klaus-Dieter Riedel; Jochen Ludwig; Johanna Weiss; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

10.  Intestinal secretion of digoxin in the rat. Augmentation by feeding activated charcoal.

Authors:  J H Caldwell; P B Caldwell; J W Murphy; C W Beachler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.